NCT07062913

Brief Summary

This study aims to evaluate the effectiveness of contrast compression therapy as an adjunct to conventional rehabilitation in patients diagnosed with complex regional pain syndrome (CRPS) following stroke. Post-stroke CRPS, previously known as shoulder-hand syndrome, is a challenging condition that affects upper extremity function and quality of life. Although various conservative treatments such as medication, physical therapy, and contrast water therapy have been used with varying success, evidence for standardized protocols remains limited. In this prospective, single-center, single-blind, randomized controlled trial, eligible patients with post-stroke CRPS type I were randomly assigned to receive either conventional rehabilitation alone or combined with contrast compression therapy. The intervention included 10 sessions of sequential thermal phases with pneumatic compression applied to the affected upper limb, delivered with a specialized device in addition to standard therapy. The primary outcome measures were pain level and edema volume. Secondary outcomes included functional recovery, spasticity, clinical motor recovery, and neuropathic pain assessments. This study aims to contribute new evidence about whether contrast compression therapy offers additional benefits for managing post-stroke CRPS.\*

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2023

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

July 3, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 14, 2025

Completed
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

July 3, 2025

Last Update Submit

July 3, 2025

Conditions

Keywords

StrokeComplex Regional Pain SyndromeContrast Compression TherapyHemiplegiaNeurorehabilitation

Outcome Measures

Primary Outcomes (2)

  • Change in Pain Intensity

    Upper extremity pain will be assessed at rest and during activity using the Visual Analog Scale.

    Baseline and after 4 weeks of treatment

  • Change in Upper Extremity Edema Volume

    Edema will be measured by the water displacement method using a hand volumeter.

    Baseline and after 4 weeks of treatment

Secondary Outcomes (4)

  • Change in Clinical Motor Recovery

    Baseline and after 4 weeks of treatment

  • Change in Neuropathic Pain Probability

    Baseline and after 4 weeks of treatment

  • Change in Spasticity

    Baseline and after 4 weeks of treatment

  • Change in Functional Independence

    Baseline and after 4 weeks of treatment

Study Arms (2)

Conventional Rehabilitation Group

ACTIVE COMPARATOR
Procedure: Conventional Rehabilitation

Contrast Compression Therapy Group

EXPERIMENTAL
Device: Contrast Compression TherapyProcedure: Conventional Rehabilitation

Interventions

A standard rehabilitation program including positioning, range of motion exercises, stretching, strengthening, and conventional transcutaneous electrical nerve stimulation.

Conventional Rehabilitation Group

Contrast compression therapy using a Game Ready® MED4 ELITE device applied to the affected upper extremity with sequential hot and cold phases and pneumatic compression.

Contrast Compression Therapy Group

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 25 and 80 years
  • First-ever stroke diagnosed within the previous 12 months
  • Diagnosis of upper-extremity complex regional pain syndrome type I (CRPS-I) according to the Budapest clinical criteria
  • Subacute-stage CRPS affecting the upper limb
  • Mini-Mental State Examination (MMSE) score greater than 23
  • Provided written informed consent

You may not qualify if:

  • Unstable medical condition
  • Hemispatial neglect
  • Sensory or motor aphasia
  • Shoulder subluxation
  • CRPS due to causes other than stroke
  • Bilateral CRPS-I
  • History of psychotic disorder
  • Coexisting neuropathic pain syndromes (e.g., diabetic neuropathy)
  • Presence of open wounds in the treatment area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara City Hospital

Ankara, Turkey (Türkiye)

Location

Related Publications (1)

  • Akinci MG, Polat CS, Tombak Demircakan A, Bukun YZ, Dalyan M. Effectiveness of contrast compression therapy for post-stroke complex regional pain syndrome: a randomized control trial. Top Stroke Rehabil. 2025 Nov 19:1-10. doi: 10.1080/10749357.2025.2589193. Online ahead of print.

MeSH Terms

Conditions

StrokeComplex Regional Pain SyndromesHemiplegia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesAutonomic Nervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

July 3, 2025

First Posted

July 14, 2025

Study Start

November 1, 2021

Primary Completion

January 9, 2023

Study Completion

January 9, 2023

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD due to patient confidentiality and ethical restrictions.

Locations